EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TM9SF1 Aggravates Liver Ischemia–Reperfusion Injury by Promoting Autophagy

Tongtong Wu, Wendong Li, Ying Zhu, Xudong Liu, Haocheng Yu, Hao Li, Jiakai Zhang, Hongwei Tang, Mingjie Ding, Wenzhi Guo

Inflammation · 2026

DOI: 10.1007/s10753-025-02410-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2026. Verfasst von Tongtong Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Hauptthemen laut MEDLINE: Autophagy, Reperfusion Injury, Liver, Membrane Proteins. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and technology innovation team in Henan Higher Education Institutions, Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University, Postdoctoral Fellowship Program of CPSF under Grant Number.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplantation (LT) remains the only effective treatment for end-stage liver disease. Autophagy critically regulates liver ischemia–reperfusion (I/R) injury. Transmembrane 9 superfamily member 1 (TM9SF1) is a transmembrane protein associated with the elevation of autophagy. However, the role and mechanism of this protein in liver I/R injury have not been explored. We observed upregulated TM9SF1 expression in liver I/R mice models and AML12 cells subjected to hypoxia-reoxygenation (H/R). Using TM9SF1 adeno-associated virus (AAV) to generate overexpression and knockdown (KD) mice with liver I/R injury, we found that TM9SF1-overexpressing mice exhibited exacerbated liver damage, inflammation, and autophagy, whereas KD-TM9SF1 mice showed opposite results. Mechanistically, we found that TM9SF1 and Annexin A2 (ANXA2) interacted and jointly promoted the expression of autophagy levels during liver I/R injury. Virtual screening of FDA-approved compounds identified lomitapide as an inhibitor that selectively suppresses TM9SF1 expression, thereby attenuating I/R injury. In general, our findings indicated that TM9SF1 and ANXA2 interact with each other, promoting autophagy levels through activating the mitogen-activated protein kinase (MAPK) pathway, thereby aggravating liver I/R injury. Targeting TM9SF1-ANXA2 may be a potential therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyReperfusion InjuryLiverMembrane ProteinsAnimalsMiceMice, Inbred C57BLMale

Stichwörter der Autor:innen

ANXA2AutophagyLiver Ischemia–Reperfusion InjuryTM9SF1

Substanzen

Membrane Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou, 450052, Henan, China.
  • Open and Key Laboratory of Hepatobiliary & Pancreatic Surgery and Digestive Organ Transplantation at Henan Province, Zhengzhou, 450052, Henan, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. fccguowz@zzu.edu.cn.
  • Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou, 450052, Henan, China. fccguowz@zzu.edu.cn.
  • Open and Key Laboratory of Hepatobiliary & Pancreatic Surgery and Digestive Organ Transplantation at Henan Province, Zhengzhou, 450052, Henan, China. fccguowz@zzu.edu.cn.

Förderung

  • Science and technology innovation team in Henan Higher Education Institutions
  • Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University
  • Postdoctoral Fellowship Program of CPSF under Grant Number
  • Gandanxiangzhao
  • National Natural Science Foundation of China

Zitieren

APA

Wu, T., Li, W., Zhu, Y., Liu, X., Yu, H., Li, H., Zhang, J., Tang, H., Ding, M., & Guo, W. (2026). TM9SF1 Aggravates Liver Ischemia–Reperfusion Injury by Promoting Autophagy. Inflammation. https://doi.org/10.1007/s10753-025-02410-5

Vancouver

Wu T, Li W, Zhu Y, Liu X, Yu H, Li H, et al. TM9SF1 Aggravates Liver Ischemia–Reperfusion Injury by Promoting Autophagy. Inflammation. 2026. doi:10.1007/s10753-025-02410-5

BibTeX
@article{Wu2026,
  author = {Wu, Tongtong and Li, Wendong and Zhu, Ying and Liu, Xudong and Yu, Haocheng and Li, Hao and Zhang, Jiakai and Tang, Hongwei and Ding, Mingjie and Guo, Wenzhi},
  title = {TM9SF1 Aggravates Liver Ischemia–Reperfusion Injury by Promoting Autophagy},
  journal = {Inflammation},
  year = {2026},
  doi = {10.1007/s10753-025-02410-5}
}
Kostenlos starten →